Exhibit 99
| |
|
|
CONTACT:
|
|
FOR IMMEDIATE RELEASE |
Chris Sharng |
|
|
Natural Health Trends |
|
|
972-241-4080 |
|
|
Chris.sharng@nhtglobal.com |
|
|
|
|
|
Deanna Decker |
|
|
Padilla Spear Beardsley |
|
|
(212) 752-8338 |
|
|
ddecker@psbpr.com |
|
|
NATURAL HEALTH TRENDS CORP. NOTIFIED OF NON-COMPLIANCE
WITH NASDAQ INDEPENDENT DIRECTOR RULE
DALLAS, March 6, 2007 Natural Health Trends Corp. (NASDAQ NMS:BHIP), an international
direct-selling company, announced today that it received a letter from The Nasdaq Stock Market
stating that the Company is not in compliance with Marketplace Rules 4350(d)(2) and 4350(c)(3).
Specifically, due to the resignation of Colin OBrien and Terrence M. Morris from the Board of
Directors and, consequently, the Companys Audit and Compensation Committees, the Companys Audit
Committee is not comprised of at least three independent directors and the Compensation Committee
is not composed of at least two independent directors.
On or before March 16, 2007, the Company is required to provide The Nasdaq Stock Market the
Companys specific plan and timetable to achieve compliance with the Rules. The Company intends to
timely submit a plan for achieving compliance to The Nasdaq Stock Market.
About Natural Health Trends Corp.
Natural Health Trends Corp. is an international direct-selling company operating through its
subsidiaries in 15 countries throughout Asia, North America, Europe and Latin America. The Company
markets premium quality personal care products under the NHT Global (formerly Lexxus International)
brand. Additional information can be found on the Companys Website, and management encourages
interested parties to register for updated corporate information via e-mail on the Companys
homepage, www.naturalhealthtrendscorp.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Forward-looking statements in this release do not constitute guarantees of future performance. Such
forward-looking statements are subject to risks and uncertainties that could cause our actual
results to differ materially from those anticipated. Such statements may relate, among other
things, to our relationship with our distributors; our need to continually recruit new
distributors; our internal controls and accounting methods may require further modification; our
need to raise additional capital if revenues continue to decline; risks related to an SEC
investigation and securities litigation; adverse consequences from audit committee investigations
or management changes; regulatory matters governing our products and network marketing system;
regulatory matters pertaining to direct-selling laws, specifically in China; our ability to recruit
and maintain key management and consultants; adverse publicity associated with our products or
direct selling organizations; product liability claims; our reliance on outside manufacturers;
risks associated with operating internationally, including foreign exchange risks; product
concentration; dependence on increased penetration of existing markets; the competitive nature of
our business; and our ability to generate sufficient cash to operate and expand our business. For
a more detailed discussion of the risks and uncertainties of our business, please refer to our
Annual Report on Form 10-K and our amended Annual Report on Form 10-K/A for the fiscal year ended
December 31, 2005 filed with the Securities and Exchange Commission. We assume no obligation to
update any forward-looking information contained in this press release or with respect to the
announcements described herein.
###